featured
FDA Approves Oral Duvyzat for Duchenne Muscular Dystrophy
Medication is the first nonsteroidal drug approved to treat all genetic variants of Duchenne muscular dystrophy in patients age 6 years and older
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.